Immune-Boosting drug tested to shield vulnerable dialysis patients from COVID-19
Prevention
Completed
This study tested whether a drug called thymalfasin (Ta1) could help prevent COVID-19 infections in people with kidney failure who receive regular dialysis. These patients are at very high risk for severe illness. Researchers gave 262 participants injections of Ta1, which is desi…
Phase: PHASE2 • Sponsor: William B. Ershler, MD • Aim: Prevention
Last updated Mar 27, 2026 12:40 UTC